Affiliated Hospital of Yangzhou University Researchers Discuss Research in Liver Cancer (Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and ...)

Cobertura de los medios

• Nombre	Affiliated Hospital of Yangzhou University Researchers Discuss Research in Liver Cancer (Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and ...)
  Nombre/canal del medio de comunicación	Cancer Daily
  País/Territorio	Estados Unidos
  Fecha	11/12/24
  Personas	Yang Yang